The Cancer Vaccine That Could Save Moderna
Moderna, once a struggling biotech startup after its pandemic-era peak, is making a dramatic comeback with a promising mRNA-based cancer vaccine that could redefine oncology treatment and revitalize its business. The breakthrough represents both a scientific milestone and a strategic pivo
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.
Guest
Xavier Martinez
narrative on The Journal.
Mentions
Books, people, and resources mentioned in this episode.
People
Companies
Products & Tools
Topics
Listen to This Episode
More from The Journal.
The Flu Shot Drama at the FDA
Novo Nordisk's CEO Has a Comeback Plan
The Great IPO Frenzy of 2026
How Big Food Is Navigating the GLP-1 Era
Musk vs. Altman
How the ‘Nostradamus of AI’ Got It Wrong
Related episodes
From other shows on similar topics.
The Global Story: Will the new cancer vaccine survive RFK Jr’s America?
Global News Podcast
Longer Life: What Does Science Say?
On with Kara Swisher
Did Moderna Just Cure Cancer? & Freight Trains Have a $200M Theft Problem
Morning Brew Daily
This breakthrough could usher in a wave of cancer vaccines
Apple News Today
The Cancer Episode
Stuff You Should Know
664. Are Thousands of Medical Cures Hiding in Plain Sight?
Freakonomics Radio
Get summaries like this every morning.
Free AI-powered recaps of The Journal. and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.